Unlike Redpoint Bio, which is currently very small (employing only 11 people) and appears to be struggling, Chromocell Corporation appears to have it all together. The privately-owned company has a Nobel Prize winner on its advisory board, talented highly educated staff, and a potentially lucrative agreement with Coca-Cola. Look a little closer though, and you realize that, although this little biotech firm is looking good, it may only be because they are the new Coca-Cola favorite in the natural sweeteners race.
The agreement was announced on December 10, 2010, four months after Coca-Cola broke from their last partner, Senomyx Inc., which apparently broke ties with Coke to work with the competition at Pepsi. Prior to that, in 2007, Coke had an agreement with the ill-fated Redpoint Bio. To be honest, I didn't know there were so many small biotech companies out there working on natural non-sugar-alternatives to food sweetening, and it makes me wonder how many more Coca-Cola will try on for size before they find the perfect match.
Klayman, B. Coke in sweetener deal with Chromocell. Reuters, Dec. 10, 2010.